|HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm|
T Van Gorp, I Cadron, E Despierre, A Daemen, K Leunen, F Amant, ...
British journal of cancer 104 (5), 863-870, 2011
|Endometriosis and the development of malignant tumours of the pelvis. A review of literature|
T Van Gorp, F Amant, P Neven, I Vergote, P Moerman
Best practice & research Clinical obstetrics & gynaecology 18 (2), 349-371, 2004
N Colombo, T Van Gorp, G Parma, F Amant, G Gatta, C Sessa, I Vergote
Critical reviews in oncology/hematology 60 (2), 159-179, 2006
|Management of borderline ovarian neoplasms|
I Cadron, K Leunen, T Van Gorp, F Amant, P Neven, I Vergote
Journal of clinical oncology 25 (20), 2928-2937, 2007
|Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome|
I Kalogiannidis, S Lambrechts, F Amant, P Neven, T Van Gorp, I Vergote
American journal of obstetrics and gynecology 196 (3), 248. e1-248. e8, 2007
|Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant …|
T Van Gorp, J Veldman, B Van Calster, I Cadron, K Leunen, F Amant, ...
European journal of cancer 48 (11), 1649-1656, 2012
|Timing of debulking surgery in advanced ovarian cancer|
I Vergote, T Van Gorp, F Amant, K Leunen, P Neven, P Berteloot
International Journal of Gynecologic Cancer 18 (Suppl 1), 2008
|Lymph node metastasis in stages I and II ovarian cancer: a review|
M Kleppe, T Wang, T Van Gorp, BFM Slangen, AJ Kruse, R Kruitwagen
Gynecologic oncology 123 (3), 610-614, 2011
|Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients|
IJG Rutten, DPJ van Dijk, RFPM Kruitwagen, RGH Beets‐Tan, ...
Journal of cachexia, sarcopenia and muscle 7 (4), 458-466, 2016
|Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance—a study of the OVCAD consortium|
E Obermayr, DC Castillo-Tong, D Pils, P Speiser, I Braicu, T Van Gorp, ...
Gynecologic oncology 128 (1), 15-21, 2013
|Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive|
B Van Calster, IV Bempt, M Drijkoningen, N Pochet, J Cheng, ...
Breast cancer research and treatment 113 (1), 181-187, 2009
|Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis|
EMJ Meys, J Kaijser, R Kruitwagen, BFM Slangen, B Van Calster, ...
European journal of cancer 58, 17-29, 2016
|Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA–IV: analysis of the OVCAD data|
S Polterauer, I Vergote, N Concin, I Braicu, R Chekerov, S Mahner, ...
International Journal of Gynecologic Cancer 22 (3), 2012
|Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer|
IJG Rutten, J Ubachs, RFPM Kruitwagen, RGH Beets‐Tan, ...
Journal of cachexia, sarcopenia and muscle 8 (4), 630-638, 2017
|Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study|
EI Braicu, C Fotopoulou, T Van Gorp, R Richter, R Chekerov, C Hall, ...
Gynecologic oncology 128 (2), 245-251, 2013
|The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma—analysis of patient data in the …|
G Hofstetter, N Concin, I Braicu, R Chekerov, J Sehouli, I Cadron, ...
Gynecologic oncology 131 (1), 15-20, 2013
|Robotic retroperitoneal lower para-aortic lymphadenectomy in cervical carcinoma: first report on the technique used in 5 patients|
I Vergote, B Pouseele, T Van Gorp, B Van Acker, K Leunen, I Cadron, ...
Acta obstetricia et gynecologica Scandinavica 87 (7), 783-787, 2008
|Laparoscopy to predict the result of primary cytoreductive surgery in patients with advanced ovarian cancer: a randomized controlled trial|
MJ Rutten, HS Van Meurs, R Van De Vrie, CA Naaktgeboren, G Fons, ...
Journal of Clinical Oncology 35 (6), 613-621, 2017
|Chemotherapy for recurrent cervical cancer|
I Cadron, T Van Gorp, F Amant, K Leunen, P Neven, I Vergote
Gynecologic oncology 107 (1), S113-S118, 2007
|A comparison between an ultrasound based prediction model (LR2) and the risk of ovarian malignancy algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass|
J Kaijser, T Van Gorp, K Van Hoorde, C Van Holsbeke, A Sayasneh, ...
Gynecologic oncology 129 (2), 377-383, 2013